Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H. Rübben1

  • 1Urologische Klinik und Poliklinik, Essen.

Onkologie
|July 7, 2001
PubMed
Summary
This summary is machine-generated.

Recent advancements in urological oncology include effective chemotherapy for metastatic testicular cancer and improved diagnostics using biomarkers like prostate-specific antigen (PSA). Surgical techniques also evolved to enhance patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas.

Onkologie·2001
Same journal

Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

Onkologie·2013
Same journal

Metastatic germ cell tumour following renal transplantation.

Onkologie·2013
Same journal

miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

Onkologie·2013
Same journal

A meta-analysis of internal mammary lymph node metastasis in breast cancer patients.

Onkologie·2013
Same journal

Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study.

Onkologie·2013
Same journal

Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.

Onkologie·2013
See all related articles

Area of Science:

  • Urological Oncology
  • Medical Diagnostics
  • Surgical Techniques

Background:

  • Urological oncology has seen significant progress in recent years.
  • Key developments include novel treatment regimens and improved diagnostic methods.

Purpose of the Study:

  • To review recent advancements in urological oncology.
  • To highlight improvements in the treatment, diagnosis, and quality of life for cancer patients.

Main Methods:

  • Review of advancements in chemotherapy, diagnostic techniques (monoclonal antibodies, molecular biology), and surgical procedures.
  • Focus on cisplatin-based chemotherapy, prostate-specific antigen (PSA), alpha-fetoprotein (AFP), and beta-human chorionic gonadotropin (beta-HCG) markers.

Main Results:

Related Experiment Videos

  • Cisplatin-based chemotherapy has dramatically improved outcomes for advanced testicular cancer.
  • Molecular and antibody-based diagnostics (PSA, AFP, beta-HCG) aid treatment decisions and follow-up.
  • Surgical innovations enhance quality of life, including bladder substitution and organ-sparing renal cell carcinoma treatments.

Conclusions:

  • Significant progress has been made in urological oncology, particularly in chemotherapy and diagnostics.
  • Advancements in surgical techniques are crucial for improving patient quality of life.
  • Biomarker advancements have transformed the management of prostate and testicular cancers.